baber/WOPTO huggingface dataset:
Patent NZ-570037-A (NZ)
Title: A plaque holder eg for botanical data and a method of making such
Inventor: HOBBS RICHARD
Filed: 2008-07-24
Abstract: A plaque or plaque holder for displaying information like botanical data for instance is disclosed. It may be made in two parts or be of one-piece construction, designed to be vandal-resistant and made from rust-proof materials.
Patent NZ-573191-A (NZ)
Title: A power component magazine, power components, a power component assembly and methods of assembly
Inventor: HARRISON MICHAEL JOHN
IPC: H02B1/21
Filed: 2007-05-17
Abstract: A power component magazine (1) which can fit multiple power components of different capacities and a method of assembling a power component magazine is disclosed. The magazine (2) has multiple sequential bays (2) that receive power components. The bays have power connectors (3) for connecting to power lines. Each connector has an AC terminal. Every AC terminal of every third connector is connected to a respective power line.
Patent NZ-574028-A (NZ)
Title: Tranilast analogues (substituted cinnamoyl anthranilate compounds) for treatment of conditions associated with firbrosis
Inventor: WILLIAMS SPENCER JOHN
IPC: A61K31/196
Filed: 2007-07-05
Abstract: Disclosed are compounds of Formula 1 or pharmaceutically acceptable salts thereof wherein the substituents are defined in the specification. Also disclosed is a process for preparing the compounds Formula 1. Also disclosed is the use of the compounds of Formula 1 for the manufacture of a medicament for treating a disease or condition characterised by inflammation and / or a benign or malignant neoplastic disease.
Patent NZ-574167-A (NZ)
Title: Closure for wine bottle with line having specified oxygen transmission rate
Inventor: CAREW DAVID
IPC: B65D41/38
Filed: 2007-06-25
Abstract: A ROTE closure for a wine bottle is disclosed. The closure is formed so that the closure, when positioned on and sealing the wine bottle, has a mean oxygen transmission rate ("OTR") level (n = > 10, where "n" is a number of samples tested) of greater than 0.0005 ml/day and less than 0.003 ml/day.
Patent NZ-575341-A (NZ)
Title: A hand held tissue sampling device having a rotatable punch holder holding a plurality of punches
Inventor: CORBETT GEOFFREY EARLE
IPC: G01N1/02
Filed: 2010-06-04
Abstract: An applicator for sampling tissue is disclosed. The applicator includes a punch drive section including an applicator punch, which operates along a first axis, means for retaining a punch holder, and a container holder section that retains and locates a container in alignment with the applicator punch. The means for retaining the punch holder is adapted to retain the punch holder that holds a plurality of punches on a frusto-conical surface, which is rotatable about a second axis, off-set from the first axis. It is located so as to position the frusto-conical surface so as to intersect the first axis and so that rotation of the means for retaining the punch holder individually locates each punch held by the punch holder into alignment with the applicator punch, between the applicator punch and the container holder section. Operation of the applicator punch causes the aligned punch to move towards the container holder section to excise a tissue sample.
Patent NZ-576279-A (NZ)
Title: Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors
Inventor: MORTENSEN DEBORAH SUE
IPC: A61K31/522
Filed: 2007-10-18
Abstract: Disclosed are purine derivatives of the formula depicted, wherein the substituents are as defined in the specification, and their use in treating or preventing cancer, an inflammatory condition, an immunological condition or a metabolic condition.
Patent NZ-578585-A (NZ)
Title: Fungicidal mixtures comprising substituted 1-methylpyrazol-4-ylcarboxanilides
Inventor: DIETZ JOCHEN
IPC: A01N37/52
Filed: 2008-02-04
Abstract: Disclosed herein is a fungicidal mixture for controlling phytopathogenic harmful fungi, comprising 1) at least one 1-methylpyrazol-4-ylcarboxanilide of formula I, wherein the substituents are as defined within the specification, 2) and at least one active compound II selected from the active compound groups of A) to G), such as azoles, strobulurins, carboxamides, carbamates, other fungicides, plant growth regulators and other heterocyclic compounds.
Patent NZ-582034-A (NZ)
Title: Arrangement to stabilise a power grid
Inventor: WOLF ERIK
IPC: H02J3/38
Filed: 2009-12-16
Abstract: Arrangement (PPT) to stabilise a grid is disclosed. The grid is coupled with a power-system via an inverter-system, while the power-system feeds in electrical power into the grid when needed. A synchronous generator (GEN) is connected with the grid and is designed to compensate sudden load-changes of the grid. The synchronous generator is a generator of an energy storage system (ESS) and is a rotating electrical generator. The energy storage-system can comprise an electrolyser (HPE), hydrogen gas-storage (GS) and a power-plant (PPT). The electrolyser can be connected to the hydrogen gas storage and the hydrogen gas-storage can be connected to the power plant. The synchronous generator (GEN) can be assigned to the power plant and the power plant can comprise a steam-turbine (ST) and/or a gas-turbine (GT). When the power plant comprises a steam turbine or a gas-turbine, the steam-turbine or the gas turbine is coupled via a shaft to the synchronous generator. When the power plant comprises a steam turbine or a gas-turbine, either both the steam-turbine and the gas-turbine are coupled via a shaft to the synchronous generator, or the arrangement comprises another synchronous generator connected with the grid and each one of the gas turbine and steam turbine are coupled via a shaft to a respective one of the synchronous generators. When surplus electrical power is delivered to the electrolyser, the electrolyser decomposes water into oxygen and hydrogen gas with use of the surplus electrical power, the hydrogen gas is stored at the hydrogen gas storage, stored hydrogen gas is supplied to the gas-turbine, which is used to provide mechanical power and exhaust heat and which is used to generate steam for a steam turbine and to drive the synchronous generator, - steam is supplied to the steam turbine, which is also used to drive the synchronous generator that is coupled to the steam turbine, and the synchronous generator produces electrical power for the grid.
Patent NZ-584244-A (NZ)
Title: Retractable lifeline assembly with cable assembly separated from braking and biasing members
Inventor: CASEBOLT SCOTT C
IPC: A62B1/10
Filed: 2008-09-25
Abstract: A retractable lifeline assembly is disclosed including a housing including a first portion and a second portion separated by a plate portion (103). The first portion includes a cable exit and the plate portion (103) includes a bore between a first cavity in the first portion and a second cavity in the second portion. A shaft (238) extends through the bore and a seal (140) is positioned proximate the plate (103) and the shaft (238) to seal the first cavity from the second cavity to prevent any contaminants from entering the second cavity. A bearing (243) is positioned proximate the plate (103) and the shaft (238) to support the shaft (238) in the housing. A cable assembly is operatively connected to the shaft (238) within the first cavity and including a cable (150) paid out through the cable exit. A brake mechanism (250) and biasing member (234) are operatively connected to the shaft within the second cavity.
Patent NZ-590251-A (NZ)
Title: A foundation pile made of two elongate metallic sections fixed together and electrically insulated from each other
Inventor: COATS DANIEL HYLTON
IPC: E02D5/28
Filed: 2010-12-24
Abstract: A pile comprising an elongate metallic upper section, an elongate metallic lower section, and at least one fixing member is disclosed. The upper and lower sections are fixed to one another so that each provides the pile with at least a substantial amount of its length. The upper and lower sections are fixed by way of the fixing member or fixing members. At least one of the upper and lower sections having an electrically non-conductive coating. The fixing member(s) have an electrically non-conductive coating or are formed from an electrically non-conducting substance. The pile is formed such that the coating(s) and/or fixing member(s) prevent the movement of electrical current and/or the creep of corrosion between the upper and lower sections.
Patent NZ-592235-A (NZ)
Title: Generating electricity from wave energy by converting an oscillation movement into rotation movement with a pressure multiplier
Inventor: LAMA ARTURO
IPC: F03B13/14
Filed: 2009-08-07
Abstract: 592235 Disclosed is a device for generating electricity from wave energy. An oscillating device (2) is included which is able to transform a thrust of a wave on a first extremity of the oscillating device (2) into kinetic energy. A motor unit is operatively connected to a second extremity of the oscillating device (2) and receives the kinetic energy transmitted to it by the oscillating device (2). An electrical rotating machine (5) is operatively connected to the motor unit and is able to produce electric energy when made to rotate by the motor unit. The oscillating device (2) includes a first thrust lever (4) with an essentially vertical extension and has a lower extremity of a concave shape able to receive the thrust from the wave acting essentially in a horizontal direction. The oscillating device (2) also includes and a second thrust lever with an essentially horizontal extension and carrying a float at an extremity of the horizontal extension. The first thrust lever (4) is hinged to the second thrust lever so as to freely oscillate and is positioned close and behind the float with respect a wave direction such that, when the float reaches a crest of the wave, the lower extremity of the first thrust lever (4) is raised above a surface of the wave.
Patent NZ-592423-A (NZ)
Title: Water separator for use in dentists with a suction motor and a three-way valve
Inventor: MOE FRIDTHJOF
IPC: A61C17/14
Filed: 2008-09-26
Abstract: Disclosed is a water separator for continuous separation of water, air and particles. Separators of this type are used by dentists as well as in other areas such as water absorbers. The separator has an inlet pipe (18) for receipt of a mixture of water, air and particles simultaneously from several sources. The separator has a main tank (1) with an upper chamber (2) connected with a lower chamber (3) by a valve (17) in the bottom of the upper chamber. The lower chamber is normally closed by a check valve (8) in the bottom of the lower chamber. A three- way valve (24) located in an air connection pipe (20) is adapted to establish a connection between the upper and lower chambers in a first position. In a second position the valve closes the connection to the upper chamber and allows atmospheric air to enter into the lower chamber. The upper chamber has a coarse filter (4) capturing particles from the liquid flow to the lower chamber. The water separator has two tanks, the main tank (1) and a safety tank (11). The two tanks are connected through a connection pipe (19) from the upper chamber in the main tank to the safety tank and also connected through the air connection pipe from the lower chamber in the main tank to the safety tank. The inlet pipe goes through the lid of the main tank, and an outlet pipe (22) goes through the lid of the safety tank. The safety tank is normally closed by a check valve (15) in the bottom. The outlet pipe is connected to a suction motor (23).
Patent NZ-595026-A (NZ)
Title: Immunological method for detecting active jcv infection
Inventor: TAOUFIK YASSINE
IPC: A61B5/00
Filed: 2010-03-03
Abstract: 595026 Provided is a method of detecting extrarenal active infection by JC Virus, In a patient candidate for an immunosuppressive treatment comprising the step of: a) screening for the presence of activated T Iymphocytes against JC virus in a 5 blood sample of said patient, by exposing said blood sample to epitopes of the virus for up to 48 hours. The infection can be in the central nervous system of said patient and immunosuppressive treatment can be by natalizumab or efalizumab.
Patent NZ-596744-A (NZ)
Title: Methanol synthesis process
Inventor: FITZPATRICK TERENCE JAMES
IPC: B01J23/00
Filed: 2010-05-24
Abstract: 596744 A methanol synthesis process is described, which comprises reacting a process gas containing hydrogen, carbon dioxide and carbon monoxide over a catalyst comprising shaped units formed from a reduced and passivated catalyst powder said powder comprising copper in the range 10-80% by weight, zinc oxide in the range 20-90% by weight, alumina in the range 5-60% by weight and optionally one or more oxidic promoter compounds selected from compounds of Mg, Cr, Mn, V, Ti, Zr, Ta, Mo, W, Si and rare earths in the range 0.01 - 10% by weight, to form a product gas, and condensing methanol, water and oxygenate by-products therefrom, wherein the total oxygenate by-product level in the condensate is below 500ppm.
Patent NZ-597967-A (NZ)
Title: Device and method for surface processing having a test station
Inventor: NOLL WERNER
IPC: B41F17/20
Filed: 2010-08-04
Abstract: 597967 Disclosed is a test station (100) for a device for treating surfaces of objects (220) with rounded cross sections and an at least partially electrically conductive outer wall. The test station (100) includes a voltage source, an electrode (110) coupled with the voltage source and a processing unit. The processing unit is configured to detect voltage changes between the electrode (110) and a respective object (220) arranged at the test station (100). The test station (100) includes devices for adjusting a distance between the electrode (110) and a respective object (220) arranged at the test station (100).
Patent NZ-599846-A (NZ)
Title: Package for tobacco-related articles
Inventor: HOLLOWAY STEVE
IPC: B65D5/66
Filed: 2010-11-18
Abstract: 599846 A package (1) for tobacco-related articles is disclosed. The package comprises a shell (2) having a front wall (10), a rear wall, two lateral walls (14) opposite to each other as well as a top side. A lid (4) is adapted to close the top side of the shell (2) when in a closed state. The lid (4) is connected to the rear wall or one of the lateral walls of the shell (2) at a hinge line and is about the hinge line for transfer from the closed state to an opened state. The lid (4) comprises a top wall, which has a front edge, a rear edge, two lateral edges and a bottom side and is adapted to close the top side of the shell (2) when the lid (4) is in its closed state. A bevelled edge wall (34, 36) extends from at least the edge of the top wall of the lid (4) opposite to the hinge line and fits into the shell (2) when the lid (4) is in its closed state.
Patent NZ-601612-A (NZ)
Title: Sgc stimulators or sgc activators alone and in combination with pde5 inhibitors for the treatment of cystic fibrosis
Inventor: SANDNER PETER
IPC: A61K31/18
Filed: 2011-02-03
Abstract: The present disclosure relates to soluble guanylate cyclase (sGC) and to phosphodiesterases (PDEs) and the pharmacology of sGC stimulators, sGC activators and PDE inhibitors. More particularly, the disclosure relates to the use of sGC stimulators and sGC activators in combination with PDE5 inhibitors for preparation of medicaments for the treatment of Cystic Fibrosis (CF). the combinations of the invention comprise: 2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]-5-(4-morpholinyl)-4,6-pyrimidinediamine (1), 2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]-5-(4-pyridinyl)-4-pyrimidinamine (2), methyl-4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carbamate (3), methyl-4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]-5-pyrimidinylcarbamate (4), 3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorbenzyl)1H-pyrazolo[3,4-b]pyridine (4a), 5-chloro-2-(5-chlorothiophene-2-sulfonylamino-N-(4-(morpholine-4-sulfonyl)-phenyl)-benzamide sodium salt (6), 2-(4-chloro-phenylsulfonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)phenyl)-benzamide (7), and/or 4-({ (4-carboxybutyl)[2-(2-{ [4-(2-phenylethyl)benzyl]oxy} phenyl)ethyl]amino} methyl) benzoic acid (5), 1-{ 6-[5-chloro-2-({ 4-trans-4-} trifluoromethyl)cyclohexyl]benzyl} oxy)phenyl]pyridin-2-yl} -5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid (8), 1-[6-(2-(2-methyl-4-(4-trifluoromethoxyphenyl)benzyloxy)-phenyl)pyridin-2-yl]-5-trifluoromethyl-pyrazole-4-carboxylic acid (9), 1[6-(3,4-dichlorophenyl)-2-pyridinyl-5-(trifluoromethyl)-1H-pyrazole-4-caboxylic acid (10), 1-({ 2-[3-chloro-5-(trifluoromethyl)phenyl]-5-methyl-1,3-thiazol-4-yl} methyl)-1H-pyrazole-4-carboxyIic acid (11), 4-({ 2-[3-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl} methyl)benzoic acid (12), 1-({ 2-[2-fluoro-3-(trifluoromethyl)phenyl]-5-methyl-1,3-thiazol-4-yl} methyl)-1H-pyrazole-4-carboxylic acid (13) with a PDE5 inhibitor selected form the group comprising Vardenafil, Sildenafil, Tadalafil, Udenafil, Oasantafil, Avanafil, Mirodenafil and Lodenafil in which the combination comprises 0.01 to 10 mg of the sGC stiumulator or activator and 2.5 to 20 mg of the PDE5 inhibitor.
Patent NZ-601920-A (NZ)
Title: New crystalline form of a cyclopropyl benzamide derivative
Inventor: UCZYNSKI MICHAEL A
IPC: A61K31/495
Filed: 2011-02-17
Abstract: ABSTRACT - 601920 The disclosure relates to a crystalline form of compound 4-{ (1S, 2S)-2-[(4-cyclobutylpiperazin-1-yl)carbonyl]-cyclopropyl} -benzamide, represented by formula (I), pharmaceutical formulations containing said compound and to the use of said active compound in therapy. Said crystalline form is suitable for use in the treatment of a disorder selected from schizophrenia, narcolepsy, excessive daytime sleepiness, obesity, attention deficit hyperactivity disorder, pain, neuropathic pain, Alzheimer’s disease, cognition deficiency, and cognition deficiency associated with schizophrenia.
Patent NZ-614009-A (NZ)
Title: Methods for synthesizing molybdopterin precursor z derivatives
Inventor: LONG XIANGTIAN
IPC: A01N57/00
Filed: 2012-02-17
Abstract: Provided herein are synthetic methods for preparing a compound of formula (I): Also provided herein are synthetic methods for preparing a compound of formula (XIII): The disclosure also provides useful intermediates, derivatives, prodrugs, and pharmaceutically acceptable salts, solvates and hydrates of the formula (I) and formula (XIII) compounds. These compounds are useful for treating diseases associated with molybdenum cofactor deficiency.
Patent NZ-615582-A (NZ)
Title: Microwave curing of carpet plastisol
Inventor: BOYD MICHAEL LINDSAY
IPC: D06M10/00
Filed: 2012-04-05
Abstract: A floor covering cured using microwaves is disclosed. The floor covering has a primary backing having a fibrous face and an underside, an optional cured precoat layer on the underside of the primary backing and a microwave cured thermoplastic backing layer fixed to the primary backing. There is also provided a method of making a floor covering comprising coating a first layer of a PVC thermoplastic resin plastisol on a support surface then tufting or implanting a fibrous material or yarn into a primary backing material. The primary backing is then layered onto the top surface of the plastisol of the first thermoplastic resin layer to form a floor covering. The floor covering so formed is dynamically microwave heated to fuse the thermoplastic layers into an integrally-fused backing layer then a pair of press rollers are used to applying a force to the floor covering heated by microwaves to cause the layers to bond. The floor covering this then cooled. Other variations of this method are disclosed. An apparatus for curing a thermoplastic backing layer of a carpet is also described. The floor covering may optionally be cut into floor tiles. An apparatus (10) is also disclosed including a microwave generator (2), a single mode travelling wave applicator (4) and a water load (6) used in the manufacture of the floor covering.
Patent NZ-615882-A (NZ)
Title: Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan
Inventor: XIN TAO
IPC: C07K5/037
Filed: 2012-03-30
Abstract: Provided are pro-drugs of D-gamma-glutamyl-[D/L] -tryptophan of Formula I wherein G is C1-8 alkyl or benzyl, T is C1-8 alkyl or benzyl, and * is a chiral carbon in a (R) or (S) configuration, provided that when * is in the (R) configuration, at least one of G and T is C-C alkyl. Further provided is the use of the pro-drugs in pharmaceutical compositions. D-gamma-glutamyl-D-tryptophan and D-gamma-glutamyl-L-tryptophan may be useful in the treatment of various diseases particularly those that are immune system related.
Patent NZ-616516-A (NZ)
Title: Process for manufacturing conjugates of improved homogeneity
Inventor: JIN SHENGJIN
IPC: A61P35/00
Filed: 2012-03-29
Abstract: Discloses a process for preparing a conjugate comprising a cell-binding agent chemically coupled to a maytansinoid, which process comprises: (a) contacting a cell-binding agent with a bifunctional crosslinking reagent in a solution having a pH of about 7.5 to about 9 at a temperature of about -10°C to about 15°C to covalently attach a linker to the cell-binding agent and thereby prepare a first mixture comprising cell-binding agents having linkers bound thereto; (b) conjugating a maytansinoid to the cell-binding agents having linkers bound thereto in the first mixture by reacting the cell-binding agents having linkers bound thereto with a maytansinoid in a solution having a pH of about 4 to about 9 to prepare a second mixture comprising (i) cell-binding agent chemically coupled through the linker to the maytansinoid, (ii) free maytansinoid, and (iii) reaction by-products; and (c) subjecting the second mixture to tangential flow filtration, selective precipitation, non-adsorptive chromatography, adsorptive filtration, adsorptive chromatography, or a combination thereof, to purify the cell binding agents chemically coupled through the linkers to the maytansinoid from the other components of the second mixture and thereby prepare a purified second mixture of cell binding agents chemically coupled through the linkers to the maytansinoid.
Patent NZ-621278-A (NZ)
Title: Aqueous suspension concentrate comprising an acid salt of dodecylguanidine
Inventor: PIROTTE ALAN
IPC: A01P3/00
Filed: 2012-08-22
Abstract: Provided is a fungicidal suspension concentrate comprising a) at least 400 g of dodine particles/L and expressed by weight based on the total weight of the composition: b) 0 to 10% of an anti-freeze compound, c) 1 to 10% of a wetting agent selected from alkylamine ethoxylates, acrylate graft copolymers, alkylphenol ethoxylates, alcohol ethoxylates, and tristyrylphenol ethoxylates, d) 0 to 2% of a dispersing agent, e) 0 to 5% of an antifoaming agent, f) remainder water wherein the median diameter of the dodine particles (d50) is 7-20 μm. The suspension may be used for the treatment of a fungal disease on crops or ornamental plants.
Patent NZ-628298-A (NZ)
Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Inventor: HEXAMER LAURA
IPC: C07D417/04
Filed: 2011-03-10
Abstract: Disclosed herein are sulfonyl benzamide compounds, and the use thereof in the treatment of bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukmia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoid malignancies of T -cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, chronic lymphocytic leukemia, myeloma, prostate cancer, small cell lung cancer or spleen cancer.